本页面由Tiger Trade Technology Pte. Ltd.提供服务

Viridian Therapeutics, Inc.

32.02
-0.4400-1.36%
成交量:67.38万
成交额:2,164.99万
市值:30.56亿
市盈率:-10.60
高:32.97
开:32.44
低:31.95
收:32.46
52周最高:33.34
52周最低:9.90
股本:9,544.20万
流通股本:8,072.30万
量比:0.59
换手率:0.83%
股息:- -
股息率:- -
每股收益(TTM):-3.0205
每股收益(LYR):-3.0722
净资产收益率:-49.89%
总资产收益率:-30.08%
市净率:9.73
市盈率(LYR):-10.42

数据加载中...

2024/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/24

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/18

重要事件披露

Form 8-K - Current report
2023/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities